Investigating whether individuals with naturally switched-off GPX1P1 and CYP4F24P are at a higher risk of nasopharyngeal cancer will enable genotyping to identify individuals at elevated risk for nasopharyngeal cancer, facilitating early interventions and improving patient outcomes. Here, GPX1P1 is linked to nasopharyngeal carcinoma.